Abstract:BACKGROUND:Lung function measures reflect the physiological state of the lung, and are essential to the diagnosis of chronic obstructive pulmonary disease (COPD). The SpiroMeta-CHARGE consortium undertook the largest genome-wide association study (GWAS) so far (n=48,201) for forced expiratory volume in 1 s (FEV1) and the ratio of FEV1 to forced vital capacity (FEV1/FVC) in the general population. The lung expression quantitative trait loci (eQTLs) study mapped the genetic architecture of gene expression in lung tissue from 1111 individuals. We used a systems genetics approach to identify single nucleotide polymorphisms (SNPs) associated with lung function that act as eQTLs and change the level of expression of their target genes in lung tissue; termed eSNPs. METHODS:The SpiroMeta-CHARGE GWAS results were integrated with lung eQTLs to map eSNPs and the genes and pathways underlying the associations in lung tissue. For comparison, a similar analysis was done in peripheral blood. The lung mRNA expression levels of the eSNP-regulated genes were tested for associations with lung function measures in 727 individuals. Additional analyses identified the pleiotropic effects of eSNPs from the published GWAS catalogue, and mapped enrichment in regulatory regions from the ENCODE project. Finally, the Connectivity Map database was used to identify potential therapeutics in silico that could reverse the COPD lung tissue gene signature. FINDINGS:SNPs associated with lung function measures were more likely to be eQTLs and vice versa. The integration mapped the specific genes underlying the GWAS signals in lung tissue. The eSNP-regulated genes were enriched for developmental and inflammatory pathways; by comparison, SNPs associated with lung function that were eQTLs in blood, but not in lung, were only involved in inflammatory pathways. Lung function eSNPs were enriched for regulatory elements and were over-represented among genes showing differential expression during fetal lung development. An mRNA gene expression signature for COPD was identified in lung tissue and compared with the Connectivity Map. This in-silico drug repurposing approach suggested several compounds that reverse the COPD gene expression signature, including a nicotine receptor antagonist. These findings represent novel therapeutic pathways for COPD. INTERPRETATION:The system genetics approach identified lung tissue genes driving the variation in lung function and susceptibility to COPD. The identification of these genes and the pathways in which they are enriched is essential to understand the pathophysiology of airway obstruction and to identify novel therapeutic targets and biomarkers for COPD, including drugs that reverse the COPD gene signature in silico. FUNDING:The research reported in this article was not specifically funded by any agency. See Acknowledgments for a full list of funders of the lung eQTL study and the Spiro-Meta CHARGE GWAS.

Differential lung gene expression identified Zscan2 and Bag6 as novel tissue repair players in an experimental COPD model

A Large Lung Gene Expression Study Identifying Fibulin-5 As A Novel Player in Tissue Repair in Copd

LSC Abstract – Systemic and Local Metabolomics Profiling Reveals Novel Insights into the Progression of Emphysema

LSC - 2024 - Developmental fibroblast growth factor 10 in pathogenesis and reversion of emphysema and PH in COPD

2D cross-omics integrated enrichment analysis reveals insights into COPD pathogenesis

Metabolomics Screening Identifies Reducedl-Carnitine to Be Associated with Progressive Emphysema

Integrated Single Cell Analysis of Human Lung Fibrosis Resolves Cellular Origins of Predictive Protein Signatures in Body Fluids

A transcriptomics-guided drug target discovery strategy identifies receptor ligands for lung regeneration

Functional Pdgfra fibroblast heterogeneity in normal and fibrotic mouse lung

Fibroblast growth factor 10 reverses cigarette smoke- and elastase-induced emphysema and pulmonary hypertension in mice

Lung fibroblast-derived extracellular vesicles and soluble factors alleviate elastase-induced lung injury

Targeting CEBPA to restore cellular identity and tissue homeostasis in pulmonary fibrosis

Mice with Lymphatic Dysfunction Develop Pathogenic Lung Tertiary Lymphoid Organs that Model an Autoimmune Emphysema Phenotype of COPD

Molecular mechanisms underlying variations in lung function: a systems genetics analysis

Integrated analysis reveals lung fibrinogen gamma chain as a biomarker for chronic obstructive pulmonary disease

Genetic ablation of the fpr1 gene confers protection from smoking-induced lung emphysema in mice

Integrative Genomics of Emphysema‐Associated Genes Reveals Potential Disease Biomarkers

Siglec-F Deficiency Prevents Fibrosis After Bleomycin-Induced Acute Lung Injury

Interpretable machine learning uncovers epithelial transcriptional rewiring and a role for Gelsolin in COPD

An amphiregulin reporter mouse enables transcriptional and clonal expansion analysis of reparative lung Treg cells

Reversal of emphysema by restoration of pulmonary endothelial cells